arrow
M

Marian S. Wettstein

thunder bay regional health sciences centre
H指数:16
被引数:1,051

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Patient-reported burden and adverse events of urodynamic investigation in adults with neurogenic lower urinary tract dysfunction

神经源性下尿路功能障碍成人患者报告的尿动力学检查负担和不良事件

2026-10-120
OAAI
Interdisciplinary Swiss consensus recommendations for follow-up after radical cystectomy and trimodal treatment for muscle-invasive bladder cancer

多学科瑞士共识:肌层浸润性膀胱癌根治性膀胱切除及三联治疗后随访建议

2026-01-010
PRE
Risk of metachronous upper tract urothelial carcinoma following non-muscle-invasive bladder cancer

非肌层浸润性膀胱癌治疗后上尿路移行细胞癌的发病风险

2025-11-010
OAAI
Outcomes of endoscopic management for upper tract urothelial carcinoma: A multi-center international cohort analysis

上尿路尿路上皮癌的内镜管理结局:一项多中心国际队列分析

2025-11-010
PRE
Development and International Evaluation of an Artificial Intelligence–based Model (PROGRxN-BCa) Using the World Health Organization 2004/2022 Grading System to Predict Progression Risk and Improve Substratification for Non–muscle-invasive Bladder Cancer

基于人工智能的模型(PROGRxN-BCa)的开发与国际评估:使用世界卫生组织2004/2022分级系统预测进展风险并改善非肌层浸润性膀胱癌的亚分层

2025-10-070
PRE
Impact of concomitant carcinoma in situ distribution on non-muscle-invasive bladder cancer progression risk

合并原位癌分布对非肌层浸润性膀胱癌进展风险的影响

2025-05-260
OAAI
Percentage of free to total PSA as a biomarker of survival in metastatic castration-resistant prostate cancer

游离总前列腺特异性抗原比值作为转移性去势抵抗性前列腺癌生存的生物标志物

2025-04-250
OAAI
Association of Free-to-Total PSA Ratio and 18F-DCFPyL Prostate-Specific Membrane Antigen PET/CT Findings in Patients with Biochemical Recurrence After Radical Prostatectomy: A Prospective Single-Center Study

游离前列腺特异性抗原与总前列腺特异性抗原比值及18F-DCFPyL前列腺特异性膜抗原 PET/CT 检查结果在根治性前列腺切除术后的生化复发患者中的关联性:一项前瞻性单中心研究

2024-09-260
PRE
Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours

在患有I期睾丸生殖细胞肿瘤的男性中,在主动监测期间使用血清miR-371a-3p检测复发

2021-12-1532
OA